Could IQIYI Stock Double by 2027? The AI Turnaround Tale
iQIYI is betting on AI to revive growth as its core subscription business falters. With Nadou Pro signing thousands o...
Analyze whether index fund returns change over time and identify conditions that alter trajectories, helping you refine your investment approach.
28,170 articlesiQIYI is betting on AI to revive growth as its core subscription business falters. With Nadou Pro signing thousands o...
A major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...
Root Insurance posted its first underwriting profit in 2025, delivering $40.3 million in net income on $1.5 billion i...
A pipeline powerhouse with a 6% payout has drawn fresh attention as inflation-linked cash flows and fixed-fee contrac...
SMR stocks like NuScale Power and Oklo have dazzled investors, but 2026 could test whether execution, not hype, drive...
U.S. markets wobbled as Opendoor dropped on margin concerns while housing demand hints kept some optimism alive. This...
Meta Platforms rolls out MTIA chips aimed at infrastructure independence and cost cuts. Analysts weigh whether will c...
As AI budgets surge, a majority of CEOs are freezing hiring even as they push capital into AI. The tension between au...
Lumentum Holdings stock zoomed after a positive investor briefing at a major industry conference and a rising price t...
Tejon Ranch (TRC) 2025 is shaping up as a pivotal year for investors tracking large-scale land development and partne...
Spotlighting two strong growth names that could exceed Summit Therapeutics in a year. Learn the catalysts, risks, and...
A single data point is grabbing attention: XRP-led real-world asset tokenization is surpassing ETH and SOL inflows. W...